• Privacy Policy
  • Terms & Conditions
Top Stocks Insider
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
Top Stocks Insider
No Result
View All Result
Home Investing

Cato Files Suit Against HHS to Obtain Medicaid Data

by
March 15, 2024
in Investing
0
Cato Files Suit Against HHS to Obtain Medicaid Data
0
SHARES
11
VIEWS
Share on FacebookShare on Twitter

Marc Joffe

“You can’t manage what you can’t measure” is an aphorism frequently applied to managing companies, but it applies equally to complex government programs like Medicaid. The federal/​state initiative reimburses medical services provided to over 80 million beneficiaries in multiple categories using a variety of service delivery mechanisms. Assessing federal and state Medicaid policies is complicated by the unavailability of comprehensive, public data.

The Centers for Medicare and Medicaid Services (CMS), a unit of the federal Department of Health and Human Services has a large trove of Medicaid payment data that could be quite helpful for policy analysis. This data resides in CMS’s Transformed Medicaid Statistical Information System (T‑MSIS).

Unfortunately, this data set is not made available to the public. Instead, interested users must purchase it at costs ranging into the tens of thousands of dollars and obtain approval from an Institutional Review Board (IRB). An IRB is a body (typically at an academic institution) that reviews research protocols to ensure that human subjects are not mistreated.

These barriers effectively limited access to detailed Medicaid data to government researchers, a few academics, and large non‐​governmental research organizations like the Urban Institute and the Kaiser Family Foundation. Taxpayer advocates and good‐​government watchdog organizations are effectively barred from obtaining this data, even though analyzing the files could well yield findings of waste and ideas for greater efficiency.

While researching our Cato Policy Analysis, Containing Medicaid Costs at the State Level, my colleague Krit Chanwong and I came across a report by the HHS Office of Inspector General (OIG) that relied on T‑MSIS data. Cato filed a Freedom of Information Act (FOIA) request with HHS asking for the T‑MSIS data that OIG analyzed.

Unfortunately, HHS allowed seven months to pass without responding to Cato’s FOIA request despite the fact that federal law mandates a response within twenty business days Consequently, Cato has decided to file suit in the Federal District Court of the District of Columbia.

The suit, which can be tracked on CourtListener, is entitled Cato Institute v. Department of Health and Human Services, case number 1:24-cv-00719. Cato is asking the court to declare HHS in violation of federal FOIA Law, order HHS to search for the data and release it (unless it is covered by a FOIA exemption), and to pay court costs.

Hopefully, the act of defending the case will compel HHS to revisit its stance on T‑MSIS data. It should be freely available to any organization that has the capacity to process and analyze very large datasets.

Previous Post

On the Nippon Steel-US Steel Deal, Politics (Again) Tops Policy

Next Post

Friday Feature: Trinity Arch Preparatory School

Next Post
Friday Feature: Trinity Arch Preparatory School

Friday Feature: Trinity Arch Preparatory School

    Fill Out & Get More Relevant News


    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

    Disclaimer: TopStocksInsider.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    • Privacy Policy
    • Terms & Conditions

    Copyright © 2024 TopStocksInsider. All Rights Reserved.

    No Result
    View All Result
    • News
    • Economy
    • Editor’s Pick
    • Investing
    • Stock

    Copyright © 2024 TopStocksInsider. All Rights Reserved.